相关实验视频

Updated: May 30, 2025

A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation

A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation

Published on: May 9, 2012

丁胺Rc可以防止德克萨米他诱导的肌肉缩,增强肌肉强度和运动功能

Aeyung Kim¹, Sang-Min Park², No Soo Kim³

¹Korean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu, Republic of Korea.

Journal of ginseng research

|January 28, 2025

概括

金色化物Rc (gRc) 防止由德甲 (DEX) 引起的肌肉损失和肌肉衰弱. 这种天然化合物可能为萨尔科佩尼亚和其他肌肉消耗疾病提供一种新的治疗方法.

科学领域:

肌肉生理学和药理学肌肉生理学和药理学
自然产品研究自然产品研究
衰老和疾病的作用

背景情况:

肌肉质量和功能随着年龄的增长而下降,增加健康风险.
像德甲 (DEX) 这样的葡萄糖皮质类药物可以诱导肌肉衰竭.
金色化物Rc (gRc) 显示了通过PGC-1α和线粒体通路进行肌肉保护的潜力.

研究的目的:

为了研究金色化物Rc (gRc) 对甲 (DEX) 诱导的肌肉缩和功能障碍的影响.
探索gRc对肌肉消耗的保护作用背后的分子机制.

主要方法:

在体外研究中,使用暴露于DEX的C2C12细胞核和肌管.
转录组分析以确定受gRc.c.影响的分子通路.
在接受DEX和gRc治疗的小鼠体内研究.
评估小鼠的肌肉质量,力量和运动能力.
分子对接以预测gRc与葡萄糖皮质体受体的相互作用.

主要成果:

gRc保护了肌细胞和肌管免受DEX诱导的细胞死亡和降解.
gRc抑制了肌肉降解蛋白,并增强了肌肉再生途径.
在小鼠中,gRc治疗逆转了DEX诱导的体重,肌肉质量和纤维大小的减少.
在小鼠中,gRc显著改善了肌肉强度和运动性能.
分子分析表明gRc可以竞争性地抑制DEX与葡萄糖皮质体受体结合.

结论:

金色化物Rc (gRc) 有效地预防和逆转德甲 (DEX) 诱导的肌肉衰竭和肌肉衰弱.
gRc显示出作为治疗萨尔科佩尼亚和类固醇诱导肌肉病的治疗剂的潜力.
对gRc机制的进一步研究可能会导致针对肌肉相关疾病的新治疗方法.

关键词:

德克萨米他是一种人参化物Rcc 肌肉缩肌肉缩肌肉缩肌肉功能肌肉功能骨架肌肉是一个骨肌肉.

更多相关视频

Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage

Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage

Published on: August 31, 2022

The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model

The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model

Published on: April 12, 2024

相关概念视频

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...